AU7999687A - Active compounds for preventing tumor metastases - Google Patents

Active compounds for preventing tumor metastases

Info

Publication number
AU7999687A
AU7999687A AU79996/87A AU7999687A AU7999687A AU 7999687 A AU7999687 A AU 7999687A AU 79996/87 A AU79996/87 A AU 79996/87A AU 7999687 A AU7999687 A AU 7999687A AU 7999687 A AU7999687 A AU 7999687A
Authority
AU
Australia
Prior art keywords
active compounds
tumor metastases
preventing tumor
preventing
metastases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU79996/87A
Other versions
AU607941B2 (en
Inventor
Lothar Daum
Franz Emling
Gerhard Keilhauer
Werner Seitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF SE
Original Assignee
BASF SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BASF SE filed Critical BASF SE
Publication of AU7999687A publication Critical patent/AU7999687A/en
Application granted granted Critical
Publication of AU607941B2 publication Critical patent/AU607941B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The use of (+)-verapamil, (+)-gallopamil, (+)-devapamil and/or (+)-emopamil for preventing tumour metastases is described.
AU79996/87A 1986-10-22 1987-10-21 Active compounds for preventing tumor metastases Ceased AU607941B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19863635931 DE3635931A1 (en) 1986-10-22 1986-10-22 ACTIVE SUBSTANCES FOR PREVENTING TUMOR METASAS
DE3635931 1986-10-22

Publications (2)

Publication Number Publication Date
AU7999687A true AU7999687A (en) 1988-04-28
AU607941B2 AU607941B2 (en) 1991-03-21

Family

ID=6312240

Family Applications (1)

Application Number Title Priority Date Filing Date
AU79996/87A Ceased AU607941B2 (en) 1986-10-22 1987-10-21 Active compounds for preventing tumor metastases

Country Status (7)

Country Link
EP (1) EP0270782B1 (en)
JP (1) JPS63264414A (en)
AT (1) ATE79255T1 (en)
AU (1) AU607941B2 (en)
DE (2) DE3635931A1 (en)
ES (1) ES2051721T3 (en)
ZA (1) ZA877900B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU604064B2 (en) * 1986-10-22 1990-12-06 Basf Aktiengesellschaft Active compounds for use in the treatment of tumors

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3826796A1 (en) * 1988-08-06 1990-02-08 Basf Ag SUBSTITUTED PHENYL ACETONITRILE FOR USE AS A RESISTANCE BREAKER
DE3928287A1 (en) * 1989-08-26 1991-02-28 Knoll Ag USE OF THE (+) - ENANTIOMER OF ANIPAMIL
WO1997044025A1 (en) * 1996-05-23 1997-11-27 G.D. Searle & Co. Pharmaceutical compositions containing non-racemic verapamil and process for optimizing the pharmaceutical activity of r- and s-verapamil
WO2002043730A1 (en) * 2000-11-29 2002-06-06 Epidauros Biotechnologie Ag Use of mdr-1 inducers for treating or preventing diseases
US20030092765A1 (en) * 2001-11-15 2003-05-15 John Kelly Treatment of abnormal increases in gastrointestinal motility with (R)-verapamil
JP6940950B2 (en) * 2014-02-10 2021-09-29 アンスティテュ・キュリＩｎｓｔｉｔｕｔ Ｃｕｒｉｅ Use of Mcoln-1 modulator to regulate cell migration

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2059985C3 (en) * 1970-12-05 1979-10-04 Knoll Ag, 6700 Ludwigshafen Right-handed, basic substituted phenylacetonitriles, processes for their preparation and pharmaceuticals containing these compounds
US4690935A (en) * 1983-03-31 1987-09-01 Wayne State University Inhibition of tumor growth and metastasis with calcium channel blocker compounds
JPH0753665B2 (en) * 1984-04-20 1995-06-07 財団法人癌研究会 Anti-metastatic agent
DE3635930A1 (en) * 1986-10-22 1988-04-28 Basf Ag ACTIVE SUBSTANCES FOR TUMOR TREATMENT

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU604064B2 (en) * 1986-10-22 1990-12-06 Basf Aktiengesellschaft Active compounds for use in the treatment of tumors

Also Published As

Publication number Publication date
ATE79255T1 (en) 1992-08-15
EP0270782A3 (en) 1990-01-03
JPS63264414A (en) 1988-11-01
EP0270782B1 (en) 1992-08-12
DE3635931A1 (en) 1988-04-28
ZA877900B (en) 1989-06-28
DE3781116D1 (en) 1992-09-17
EP0270782A2 (en) 1988-06-15
AU607941B2 (en) 1991-03-21
ES2051721T3 (en) 1994-07-01

Similar Documents

Publication Publication Date Title
AU6800987A (en) Hyperthermic treatment of tumors
FI874671A0 (en) ANORDINATION FOR THE CONDUCT OF THE TREATMENT.
AU1083992A (en) Formulations of d-cycloserine as cognitive enhancers
NO162238C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1,4-DIHYDRO-4-OXONAFTYRIDINE INGREDIATES.
NO166080C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 5,6,8-TRIFLUORKINOLINES.
NO864674D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CEFEM RELATIONS.
AU6142186A (en) Use of melatonin or related compounds for the treatment of psoriasis
AU5641886A (en) 5-Pyrimidinecarboxamides and treatment of leukemia and tumors therewith
AU7999687A (en) Active compounds for preventing tumor metastases
AU2158688A (en) Use of bezafibrate for treating diabetes
NO172098C (en) dentifrices
NO165069C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CYCLOPENTYLETERS.
DE3565722D1 (en) Stabilized enzyme conjugate composition
AU5684086A (en) Use of an aqueous chlorite matrix solution for the treatment of tumors
DE3689289D1 (en) Stabilization of polyolefins.
AU569354B2 (en) (-)-1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane
SE8500845L (en) PROCEDURE FOR THE PREPARATION OF GLYOXYLYLYL PERMIDINE AND ITS USE FOR PREPARATION OF 15-DEOXISPERGUALIN-RELATED COMPOUNDS
AU7071487A (en) Chlorpheniramine therapy
FI860247A0 (en) PROCEDURE FOR FRAMSTATION OF 4,4-DIALKYL-2-AZETIDINONER.
NO170936C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE, SUBSTITUTED VINYL Cephalosporins
EP0401262A4 (en) 24r-scymnol, and preparation and use thereof
AU6243186A (en) A pharmaceutical composition for the treatment of high blood pressure
AU549670B2 (en) Treatment of malignant tumours with 2- -d-ribofuranosyl- thiazole-4-carboxamide + similar compounds
NO884635L (en) PROCEDURE FOR TREATMENT OF FEEDS.
NO862454L (en) PROCEDURE FOR THE TREATMENT OF PEROXYDE WHITE DISPOSAL.